189 related articles for article (PubMed ID: 18704345)
1. [Alitretinoin: a new treatment option for chronic refractory hand eczema].
Molin S; Ruzicka T
Hautarzt; 2008 Sep; 59(9):703-4, 706-9. PubMed ID: 18704345
[TBL] [Abstract][Full Text] [Related]
2. Alitretinoin for the treatment of severe chronic hand eczema.
Paulden M; Rodgers M; Griffin S; Slack R; Duffy S; Ingram JR; Woolacott N; Sculpher M
Health Technol Assess; 2010 May; 14 Suppl 1():39-46. PubMed ID: 20507802
[TBL] [Abstract][Full Text] [Related]
3. [Off-label use of alitretinoin].
Fritz K; Tiplica GS; Salavastru C; Onder M
Hautarzt; 2013 Oct; 64(10):748-51. PubMed ID: 24150823
[TBL] [Abstract][Full Text] [Related]
4. Everyday clinical experience of alitretinoin in the treatment of severe chronic hand eczema: seven case studies.
English J; Graham-Brown R; de Sica Chapman A; Alexandroff AB
Clin Exp Dermatol; 2011 Mar; 36 Suppl():1-2. PubMed ID: 21309810
[TBL] [Abstract][Full Text] [Related]
5. Nail improvement during alitretinoin treatment: three case reports and review of the literature.
Milanesi N; D'Erme AM; Gola M
Clin Exp Dermatol; 2015 Jul; 40(5):533-6. PubMed ID: 25682921
[TBL] [Abstract][Full Text] [Related]
6. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
Bissonnette R; Worm M; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown TC
Br J Dermatol; 2010 Feb; 162(2):420-6. PubMed ID: 19906075
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
[TBL] [Abstract][Full Text] [Related]
8. Alitretinoin for severe chronic hand eczema: a NICE single technology appraisal.
Rodgers M; Griffin S; Paulden M; Slack R; Duffy S; Ingram JR; Woolacott N; Sculpher M
Pharmacoeconomics; 2010; 28(5):351-62. PubMed ID: 20131924
[TBL] [Abstract][Full Text] [Related]
9. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
Fowler JF; Graff O; Hamedani AG
J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
[TBL] [Abstract][Full Text] [Related]
10. Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema.
Kumari V; Timm K; Kühl AA; Heine G; Worm M
Br J Dermatol; 2016 Dec; 175(6):1243-1250. PubMed ID: 27480504
[TBL] [Abstract][Full Text] [Related]
11. Effects of alitretinoin on quality of life of patients having chronic hand eczema: an observational study.
Gola M; D'Erme AM; Milanesi N; Marmugi L
Dermatitis; 2013; 24(4):166-9. PubMed ID: 23857016
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation and assessment of the therapeutic efficacy of alitretinoin in a group of patients with chronic hand eczema refractory to topical steroid therapy.
Gola M; Milanesi N; D'Erme AM
G Ital Dermatol Venereol; 2014 Aug; 149(4):435-9. PubMed ID: 25068232
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of alitretinoin in severe chronic hand eczema: PASSION, a real-world observational study.
Thaçi D; Augustin M; Westermayer B; Kamps A; Hennig M
J Dermatolog Treat; 2016 Nov; 27(6):577-583. PubMed ID: 27618281
[TBL] [Abstract][Full Text] [Related]
14. [Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: experience in 15 patients].
Aguayo-Leiva IR; Urrutia S; Jaén-Olasolo P
Actas Dermosifiliogr; 2011 Oct; 102(8):616-22. PubMed ID: 21354545
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of alitretinoin depending on the concomitant use of topical corticosteroids in chronic hand eczema patients.
Cheon DU; Kim JE; Ko JY; Ro YS
J Dermatol; 2019 Nov; 46(11):998-1005. PubMed ID: 31535403
[TBL] [Abstract][Full Text] [Related]
16. Safe and effective use of alitretinoin in children with recalcitrant hand eczema and other dermatoses - a retrospective analysis.
Luchsinger I; Vogler T; Schwieger-Briel A; Knöpfel N; Wälchli R; Weibel L; Theiler M
J Eur Acad Dermatol Venereol; 2020 May; 34(5):1037-1042. PubMed ID: 31742759
[TBL] [Abstract][Full Text] [Related]
17. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.
Dirschka T; Reich K; Bissonnette R; Maares J; Brown T; Diepgen TL
Clin Exp Dermatol; 2011 Mar; 36(2):149-54. PubMed ID: 21070335
[TBL] [Abstract][Full Text] [Related]
18. Alitretinoin: A Review in Severe Chronic Hand Eczema.
Blair HA; Scott LJ
Drugs; 2016 Sep; 76(13):1271-1279. PubMed ID: 27438290
[TBL] [Abstract][Full Text] [Related]
19. Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillance.
Morris M; Schifano L; Fong R; Graff O
J Dermatolog Treat; 2016; 27(1):54-8. PubMed ID: 25886084
[TBL] [Abstract][Full Text] [Related]
20. Alitretinoin for the treatment of severe chronic eczema of the hands.
Napolitano M; Potestio L; De Lucia M; Nocerino M; Fabbrocini G; Patruno C
Expert Opin Pharmacother; 2022 Feb; 23(2):159-167. PubMed ID: 34789049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
